Combination therapy with ampicillin and azithromycin in an experimental pneumococcal pneumonia is bactericidal and effective in down regulating inflammation in mice

An Italian Experience of Sequential Intravenous and Oral Azithromycin Plus Intravenous Ampicillin/Sulbactam in Hospitalized Patients with Community-Acquired Pneumonia

(2014) T. Todisco et al.   JOURNAL OF CHEMOTHERAPY

Risk Factors for Drug-resistant Streptococcus pneumoniae and Antibiotic Prescribing Practices in Outpatient Community-acquired Pneumonia

(2012) Timothy C. Jenkins et al.   ACADEMIC EMERGENCY MEDICINE

Comparative evaluation of synergy of combinations of  -lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae

(2011) L. Drago et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Toll-Like Receptor 2 Mediates Fatal Immunopathology in Mice During Treatment of Secondary Pneumococcal Pneumonia Following Influenza

(2011) Åsa Karlström et al.   JOURNAL OF INFECTIOUS DISEASES

Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteria

(2010) M. J. Stables et al.   BLOOD

Impact of intravenous  -lactam/macrolide versus  -lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia

(2009) A. Tessmer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Treatment with Protein Synthesis Inhibitors Improves Outcomes of Secondary Bacterial Pneumonia after Influenza

(2008) Åsa Karlström et al.   JOURNAL OF INFECTIOUS DISEASES